3H Medi Solution

What 3H Medi Solution does

3H Medi Solution (3Hメディソリューション株式会社) is a Tokyo-headquartered, privately held healthcare services company that operates Japan's largest direct-to-patient clinical trial volunteer platform and provides integrated clinical research services to pharmaceutical, biotech, and healthcare clients. Founded in 2005 as Limited Company Clinical Trial and rebranded under the M3 Group umbrella in 2022, 3H runs the Seikatsu Kojo WEB platform with 1.11M+ registered members, the Oncolo cancer portal, and the RareS rare disease portal — collectively reaching 11M+ monthly page views. The company also maintains proprietary technology including the P-Guardian ePRO system, the Uchiken DCT/eConsent platform, the cPhone standardized device rental service (10,000+ units deployed), and a clinical trials dashboard built on ClinicalTrials.gov data.

The company's core business spans patient recruitment (PRO), full-service CRO operations, decentralized clinical trial (DCT) implementation, ePRO deployment, patient survey and patient preference research, and marketing/promotion services through its owned media platforms. It maintains 225+ DCT-enabled clinical sites and 280+ GCP-qualified home nurses covering all of Japan, plus an Asia patient recruitment network spanning Korea, Taiwan, China, and India. Revenue is generated primarily through project-based professional services fees (PRO/CRO/DCT), supplemented by subscription/recurring IT licensing, hardware rental (cPhone), and unit-priced advertising on Seikatsu Kojo WEB.

Go-to-market is sales-led targeting enterprise pharmaceutical sponsors (90%+ of global Top 20 pharma and 100% of Japan Top 20 pharma have used the PRO service) complemented by event-driven thought leadership (Pharma IT & Digital Health Expo, SCOPE 2026) and ecosystem distribution via M3 Group's m3.com platform of 700K+ physicians. The company merged with subsidiary 3H Clinical Trial Inc. in May 2024 and is led by representative director Takizawa Hirotaka following a May 2023 leadership transition.

Name

3H Medi Solution

Legal name

3H Medi Solution Inc.

Website

https://3h-ms.co.jp

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

251–500 employees

Short description

3H Medi Solution is a Tokyo-based, M3 Group subsidiary operating Japan's largest clinical trial volunteer platform (1.11M+ members) and providing integrated PRO, CRO, DCT, ePRO, and patient survey services to pharmaceutical, biotech, and healthcare clients across Japan and Asia.

Ownership category

akta.pro rank

Product category

Clinical Research Services (Patient Recruitment, CRO, SMO, DCT)

NAICS

Home Health Care Services (62161), Scientific Research and Development Services (5417)

SIC

Services-Home Health Care Services (8082), Services-Health Services (8000)

akta.pro primary industry

Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)

akta.pro secondary industries

Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Post-Acute & Hospital-at-Home Remote Care Platforms (HLACAFAB)

Keywords

• Clinical trial patient recruitment
• Decentralized clinical trials
• Clinical research organization services
• Electronic patient-reported outcomes
• Patient preference studies

Headquarters

HQ city

Toshima

HQ country

Japan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Patient Recruitment / PRO Services: Fees for patient recruitment (subject/monitor recruitment) services for clinical trials. Includes advertising, database querying, screening, and referral of qualified subjects to clinical trial sites. Part of SMO and CRO service bundles.
2. CRO (Clinical Research Organization) Services: Full-service clinical research support including protocol design, IRB submissions, study management, data collection, statistical analysis, and medical writing. Conducted via subsidiary 3H Clinical Trial and partnerships.
3. DCT (Decentralized Clinical Trial) Services: Bundle of services including eConsent, ePRO, home nursing, device rental/provisioning for decentralized trials. Revenue from study-specific project fees.
4. Patient Survey / Market Research: Patient-centered research services including qualitative interviews, quantitative surveys, MROC (online community), discrete choice experiments, and patient journey mapping. Also includes PPS (Patient Preference Studies) for regulatory submissions.
5. Promotion / Advertising Services: Marketing and promotion services leveraging the Seikatsu Kojo WEB platform. Includes email newsletter advertising, LINE messaging campaigns, and website banner placements with audience segmentation.
6. IT / Healthcare Technology Solutions: ePRO system (P-Guardian), clinical data platforms, app development, and DCT technology systems. May include subscription or per-study licensing components.
7. Device Rental (cPhone): Rental of standardized smartphones and IoT devices for clinical trials. Fees based on contract duration and device specifications.
8. Biological Sample Recruitment Services: Recruitment of patients willing to provide biological samples (blood, urine, tissue) for research. Matches patients to researchers under ethical oversight frameworks (PCRD2).

Pricing tiers

Go-to-market motion2 records

Distribution channels9 records

Marketing channels10 records

Core offering

3H Medi Solution provides end-to-end clinical trial support services for pharmaceutical, biotech, and medical device sponsors, including patient recruitment (PRO) sourced from Japan's largest direct-to-patient volunteer database (~1.1M registered members), CRO and SMO clinical research operations, decentralized clinical trial (DCT) execution via its Uchiken platform and 280+ GCP-qualified home nurses, electronic patient-reported outcome collection through its 3H P-Guardian system, clinical-trial device rental through cPhone, and patient survey / patient preference (PPS) research. The company also operates consumer-facing patient media platforms (Seikatsu Kojo WEB, Oncolo, RareS) that feed its recruitment funnel and support advertising-based promotion services.

Differentiator

Problem solved

Functional benefit

Brands

• Uchiken (ウチケン): Visit nursing station specialized in clinical trials; provides home-based clinical trial support services for DCT implementation
• 3H P-Guardian (スリーエイチピーガーディアン)
• cPhone
• 生活向上WEB「マイカルテ」(Seikatsu Kojo WEB My Karute)
• Clinical Trials Dashboard
• 患者インサイトパック (Patient Insight Pack)
• PCRD² (Patient Centricity in Rare Disease R&D Program)

Products and services

• Patient Recruitment (PRO) Services Advertising, database querying, screening, and referral of qualified subjects to clinical trial sites; bundled with SMO and CRO services for pharma and biotech sponsors.
• CRO (Clinical Research Organization) Services Full-service clinical research support including protocol design, IRB submissions, study management, data collection, statistical analysis, and medical writing, delivered via subsidiary 3H Clinical Trial and partnerships.
• SMO (Site Management Organization) Services Site management services supporting hospitals and clinics conducting clinical trials, including coordinator staffing, SOP development, and trial site operations.
• DCT (Decentralized Clinical Trial) Support Services Bundle of services including eConsent (Uchiken), ePRO, home nursing (Uchiken visiting nurses), and cPhone device rental for decentralized clinical trials, with study-specific project fees.
• 3H P-Guardian ePRO System Electronic patient-reported outcome (ePRO) system for clinical research and real-world practice, enabling real-time data collection via smartphone/tablet, with questionnaire scheduling, alerts, PDF/CSV export, caregiver sharing, and regulatory compliance.
• Uchiken DCT / eConsent Platform Remote electronic consent (eConsent) platform combining Zoom Meeting video conferencing and DocuSign eSignature, supporting online informed consent for clinical trials without in-person hospital visits, with version management, multi-party meetings, audit trails, and PDF reports.
• cPhone Device Rental Service Standardized smartphone rental service for clinical trial participants, providing a unified device environment with restricted apps, DTx trial device assignment, remote lock/wipe, and 24/7 helpdesk, with over 10,000 units deployed.
• Patient Survey and Patient Preference Study (PPS) Services Patient-centered research services including qualitative interviews, quantitative surveys, MROC (online community), discrete choice experiments, and patient journey mapping; PPS for regulatory submissions (ICH E22 compliance).
• Asia Patient Recruitment Network (APRO) Pan-Asian patient recruitment services enabling coordinated cross-border clinical trial patient recruitment across Asian countries via partners in Korea, Taiwan, China, and India.
• PCRD2 Patient-Centricity in Rare Disease R&D Program Framework for matching rare disease patients who wish to participate in research with investigators needing specimens and health information, including ethical committee review and patient feedback of research results.
• Seikatsu Kojo WEB Patient Platform and Promotion Services Japan's largest direct-to-patient clinical trial volunteer platform with 1.1M+ registered members and 220+ disease category PHR data, used for clinical trial recruitment funnels and promotional/advertising services.
• Oncolo Cancer Information Portal Oncology-focused information portal with 200K+ monthly unique visitors, providing cancer clinical trial information, expert seminars, and patient support content; co-hosts 40+ online seminars per year with cancer research organizations.
• RareS Rare Disease Portal Rare disease information and community platform covering 330 designated intractable diseases and 47 rare cancers, connecting patient advocacy groups with rare disease patients.
• Biological Sample Recruitment Services Recruitment of patients willing to provide biological samples (blood, urine, tissue) for research, matching patients to researchers under ethical oversight frameworks including PCRD2.
• DCT Implementation PoC Service Proof-of-concept service for DCT adoption including study planning, device selection, app development, patient recruitment, IRB support, and RAW data delivery; covers 15+ completed PoC cases.
• Help Desk and Administrative Support Services Call center and administrative support for clinical trials, including inbound/outbound patient calls, study coordination, and 24/7 helpdesk support, anchored by the Miyazaki Contact Center.

Quantifiable outcome

• 10,000+ patient randomizations per year
• +5 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability6 records

Feature12 records

Partnerships

15 partnerships are on record, tiered minor, core and flagship.

• Merck BioPharma (メルクバイオファーマ)minorGTM or Marketing Partner · 1 July 2025Collaboration to launch 'Oncolo for Seniors' (オンコロforシニア), a simplified cancer information website for elderly patients, operated by Oncolo with Merck BioPharma.
• GeneQuest (株式会社ジーンクエスト)coreStrategic or Co-development Partner · 1 September 2023Joint research collaboration to build patient registries combining genetic information with clinical data. Successfully constructed IBD (inflammatory bowel disease) patient registry of 100 patients. Also built genetic + clinical database for pharmacogenomic analysis and precision patient recruitment.
• AstraZenecaminorGTM or Marketing Partner · 1 July 2023Oncolo cancer portal collaboration on gastric cancer awareness campaigns with AstraZeneca.
• QLife (株式会社QLife)coreStrategic or Co-development Partner · 1 March 2023Joint patient recruitment services combining 3H's clinical trial volunteer database with QLife's patient media platforms and healthcare provider network. Combined PRO operations serve the M3 Group ecosystem.
• THREAD ResearchcoreTechnology or Integration · 1 February 20233H became a certified implementation partner for THREAD's DCT platform in Japan. 3H provides patient recruitment, home nursing, and DCT consulting services integrated with THREAD's technology platform for sponsors adopting DCT in Japan.
• Four H (合同会社Four H)minorStrategic or Co-development Partner · 1 January 2023Joint venture company established with HYPER CUBE for specialized clinical research services.
• M3 Group (エムスリーグループ)flagshipStrategic or Co-development Partner · 1 February 20223H became part of the M3 Group in February 2022, gaining access to M3's ecosystem including 700K+ physicians on m3.com, integrated CRO/SMO services (MediScience Planning, Noes), home nursing (Sofia Med), and patient recruitment synergies across the group.
• Science 37coreTechnology or Integration · 1 October 2021Strategic partnership to enable DCT (decentralized clinical trials) and promote patient enrollment in Japan. Science 37 provided its DCT technology platform while 3H contributed patient recruitment and home nursing capabilities.
• Patient Centricity Promotion Center (Patient Centricity推進センター)coreStrategic or Co-development Partner · 1 January 2021Participation in the Patient Centricity Promotion Center co-founded by MediScience Planning and QLife (2021). Aims to accelerate patient-centric drug development in Japan through PPI (Patient and Public Involvement).
• Eisai Healthcare (エイツーヘルスケア)minorStrategic or Co-development Partner · 1 November 2019Business partnership aimed at promoting patient engagement in drug development. Combined 3H's patient recruitment and survey capabilities with Eisai's pharmaceutical development expertise.
• Tokyo University / 3H Holdings / Neo Pharma JapancoreStrategic or Co-development Partner · 1 May 2019Launched Patient Centricity in Rare Disease R&D Program (PCRD2) to connect rare disease patients willing to participate in research with investigators needing specimens and health information.
• Tokyo University Graduate School of Pharmaceutical Sciences (東京大学 大学院薬学系研究科)coreStrategic or Co-development Partner · 1 November 2018IT Healthcare Social Collaboration Research joint research program (2018-2021). Co-developed PCRD2 (Patient Centric Rare Disease R&D Program) with Tokyo University for matching rare disease patients with researchers. Includes research themes on DCT paradigm shift and patient-centric drug development.
• Intellim (インテリム)minorStrategic or Co-development Partner · 1 October 2016Partnership with Intellim for the Oncolo cancer portal, combining oncology clinical trial information and support services.
• EPS (イーピーエス)minorStrategic or Co-development Partner · 1 July 2016Strategic cooperation in patient recruitment with EPS, one of Japan's largest CROs.
• Asia Patient Recruitment Network (APRO)coreStrategic or Co-development Partner · 1 February 2015First Asia-based patient recruitment network established by 3H, enabling coordinated cross-border clinical trial patient recruitment across Asian countries.

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

Market position

Strengths1 record

Competitive moat6 records

Key risks2 records

Key highlights7 records

Customer concentration

• Xtwitter.com/3h_ms
• LinkedInlinkedin.com/company/3hmedisolution

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 3H Medi Solution